In vitro screening of thiacetazone derivatives indicated that two derivatives, SRI-286 and SRI-224, inhibited a panel of 25 Mycobacterium avium complex (MAC) isolates at concentrations of 2 micro g/ml or lower. In mice, SRI-224 and thiacetazone had no significant activity against the MAC in livers and spleens, but treatment with SRI-286 resulted in significant reduction of bacterial loads in livers and spleens. A combination of SRI-286 and moxifloxacin was significantly more active than single drug regimens in liver and spleen.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166073 | PMC |
| http://dx.doi.org/10.1128/AAC.47.8.2685-2687.2003 | DOI Listing |
Publication Analysis
Top Keywords
mycobacterium avium
8
livers spleens
8
thiosemicarbazole thiacetazone-like
4
thiacetazone-like compound
4
compound activity
4
activity mycobacterium
4
avium mice
4
mice vitro
4
vitro screening
4
screening thiacetazone
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!